Related Experiment Video
Updated: May 9, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Familial pheochromocytomas and paragangliomas
1Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.
Pheochromocytomas and paragangliomas are tumors linked to 13 genetic susceptibility genes. Understanding these genetic links improves diagnosis and treatment for patients with these rare neuroendocrine tumors.
Area of Science:
- Endocrinology and Oncology
- Neurobiology and Genetics
Background:
- Pheochromocytomas and paragangliomas are neural crest tumors associated with catecholamine production.
- Thirteen susceptibility genes are linked to tumor development, with specific genes correlating to clinical and biochemical profiles.
- Somatic mutations and immunohistochemistry play crucial roles in pheochromocytoma/paraganglioma development and genetic testing.
Purpose of the Study:
- To review the current understanding of genetic predispositions in pheochromocytoma and paraganglioma.
- To highlight advances in genetic testing strategies for these tumors.
- To emphasize the impact of genetic discoveries on patient diagnosis and management.
Main Methods:
- Review of scientific literature on pheochromocytoma and paraganglioma genetics.
- Analysis of the association between susceptibility genes and tumor characteristics.
- Evaluation of the role of somatic mutations and immunohistochemistry in genetic testing.
Main Results:
- Established links between 13 susceptibility genes and pheochromocytoma/paraganglioma development.
- Correlation of specific genes with clinical presentation, biochemical findings, tumor location, and associated neoplasms.
- Demonstrated utility of immunohistochemistry in guiding genetic testing decisions.
Conclusions:
- Genetic insights have significantly advanced the understanding of pheochromocytoma and paraganglioma.
- Organized genetic testing approaches reduce patient burden.
- Genetic discoveries pave the way for improved diagnosis and targeted treatments.
Related Concept Videos
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Sympathetic Pathways: Collateral Ganglia and Adrenal Medulla
Collateral Ganglia
Sympathetic preganglionic axons reach the collateral ganglia along the route of splanchnic nerves. These nerves bypass the sympathetic trunk and communicate with sympathetic postganglionic neurons housed in the prevertebral ganglia. These ganglia supply the organs of the abdominopelvic cavity.
The greater splanchnic nerve, formed by the...
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Sympathetic Pathways: Sympathetic Chain Ganglia
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Peripheral Nervous System: Ganglia and Nerves
Nerves
The nerve is a bundle of axons that serves as the communication highway in the PNS. Each nerve is ensheathed in a protective layer of connective tissue called the epineurium. This outermost layer safeguards the nerve and supports the...
